GLP-1 compounded

1/Wk In-Clinic Weight Loss Injection

GLP-1 compounded: ONCE A WEEK INJECTION

GLP-1 is widely seen as a breakthrough: "a new paradigm for the hormonal treatment of obesity. Experts are calling it a "game changer in obesity medicine.

GLP-1 is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. Treatment of tvpe 2 diabetes and for weight loss in adults who want to lose weight.

It functions by lowering appetite and fostering feelings of fullness, and it is administered once per week. But it must be used under medical supervision as part of a weight loss strategy that also involves exercise and a diet low in calories.

CLINICAL TRIALS

In clinical trials, patients lost an average of 15% of their body weight. Weight loss may stall after a certain amount of time if the medicine is not used in conjunction with a low-calorie diet and regular exercise.

It is also crucial to note that GLP-1 compounded may result in some side effects, including nausea, exhaustion, diarrhea, and constipation. These side effects, however, are typically transient and can be handled by adjusting the dosage or by taking the prescription with meals.

Low doses allow the body to gradually adjust to the medication, which can help reduce the likelihood and severity of side effects such as nausea, vomiting, and diarrhea, especially when it is first started. It’s important to note that the decision to prescribe GLP-1 compounded is made on an individual basis and depends on a variety of factors, including the person’s overall health, the severity of their diabetes, and their response to other treatments.

We will begin with a low dose and gradually increase it over the course to the maximum allowable dose per week.

“With 17 years of trusted experience, we offer exceptional clinical support at the most affordable prices. Excellence in care. Expertise you can trust. Affordability you’ll love.”

GLP-1 Injection as a once-weekly subcutaneous injection is administered “IN-CLINIC”

This "Pay-As-You-Go" approach can provide more flexibility for those that need more frequent monitoring and potential adjustments.

NOT SUITABLE FOR​

With TYPE 2 Diabetes OR Diabetic Ketoacidosis:

GLP-1 medication is not recommended for Type 1 Diabetes, specifically, if you are prescribed Insulin because the combination may increase your risk of hypoglycemia (low blood sugar).

With History of Pancreatitis:

There have been cases of pancreatitis in patients taking GLP-1 Injection, so if you’ve had pancreatitis in the past, this medication might not be right for you

With history of MEDULLARY THYROID CARCINOMA (MC) or MULTIPLE ENDOCRINE NEOPLASIA SYNDROME TYPE 2 (MENS 2):

As it is associated with an increased risk of thyroid-C cell tumors in individuals with a personal or family history of MTC.

Severe Gastrointestinal Disease:

For individual with preexisting severe gastroparesis or IBD side effects can worsen.

Pregnant Woman:

GLP-1 medication is contraindicated for use during pregnancy to avoid any potential risks to the developing baby. If you're pregnant or planning to become pregnant, consult your healthcare provider before starting GLP-1.

Common Side Effects:

Dry mouth, discomfort at the injection site, tiredness, headache, neck pain, and eye issues like double vision or drooping eyelids may occur.

  • YES. Semaglutide GLP-1 agonist is primarily used to treat type 2 diabetes but has also been approved for weight management.

  • Semaglutide GLP-1 works by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels and appetite. It slows down digestion, reduces hunger, and increases feelings of fullness, leading to decreased food intake and subsequent weight loss.

  • Yes, GLP-1 compounded has been approved by regulatory authorities in some countries for chronic weight management in adults with a body mass index (BMI) of 30 or higher, or with a BMI of 27 or higher in the presence of at least one weight-related comorbidity, such as high blood pressure or type 2 diabetes

  • The recommended starting dose of GLP-1 for weight loss is 0.25 mg once weekly, which is gradually increased to 2.4 mg over a period of 16 weeks. The higher dose of 2.4 mg is the maintenance dose for continued treatment.

  • The most common side effects of Semaglutide for weight loss include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, and headache. These side effects are usually mild to moderate and tend to improve over time.

  • GLP-1 is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). It should also be avoided in individuals with a history of severe gastrointestinal disease or a hypersensitivity to GLP-1. Retinopathy (loss of vision), Type 1 diabetics.

  • In clinical trials, Semaglutide has been shown to help people achieve significant weight loss. On average, participants lost around 15% of their body weight over the course of the studies. However, individual results may vary.

  • In order to achieve long-term success with GLP-1, it is important to incorporate healthy eating habits and exercise. Failing to do so increases the risk of regaining weight once GLP-1 is discontinued. Gaining weight is expected for any diet that does not address food-related behavior changes.

  • GLP-1 compounded is NOTcovered by insurance however our offer is highly competitive.